Substituted quinoxalines as positive allosteric modulators of mGluR4
US9763938B2 · kind B2 · utility
0Cited by
1References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 14, 2016 |
| Grant date | Sep 19, 2017 |
| Priority date | — |
| Expiry date | Jul 14, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of novel quinoxaline derivatives of formula (I)as positive allosteric modulators for modulating metabotropic glutamate receptor subtype 4 (mGluR4) and/or altering glutamate level or glutamatergic signalling.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.